Company
Every investor coverage indicates participated in a round SYMBYX raised.
Companies SYMBYX acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Wayne Markman | CEO | Forbes Australia |
Stories naming SYMBYX. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Profile of SYMBYX, an Australian medtech firm using light therapy lasers to ease Parkinson's symptoms, naming its high-profile investors including ResMed's Peter Farrell and noting clinical trials underway.